Midi Health presents its menopause care around clinical appointments, with a pricing and insurance page that separates first visits from returning visits. That makes the appointment structure easier to understand than a single medication-price headline. It also gives readers a concrete set of questions to bring to a benefits check.
This review examines Midi’s public pricing and insurance information checked October 3, 2026. We have not attended an appointment, verified an individual reader’s coverage, or evaluated treatment outcomes. The published table is a starting point for a quote, not confirmation that your care will be free or available in your circumstances.
What the self-pay figures describe
Midi’s table lists a first 30-minute self-pay visit at $250 and a returning 15-minute self-pay visit at $150. These are visit prices with different durations. They should not be compared directly with a competing provider’s monthly medication starting price or a consultation fee with another scope.
Before booking, ask whether the expected appointment is the first-visit or returning-visit type, how a longer or additional visit would be billed, and what else may cost extra. We do not treat the table as evidence that every medication, laboratory test, or outside service is included.
Continue with What will the visit actually cost? Ask for the whole picture.
Use the exact insurance plan
The page offers a state and insurance-plan checker and describes relationships with many commercial plans. Its insured column uses the word covered. That does not tell a reader whether a deductible is met or what copay or coinsurance applies. Confirm the particular plan and service rather than relying on a familiar insurer logo.
Midi’s published information describes Medicare as out of network and distinguishes its self-pay arrangements from claims for associated services. It says it does not currently accept Medicaid or Medi-Cal. If those programs apply to you, ask direct questions before booking; do not infer eligibility from the commercial-plan table.
Think about the return visit before the first one
Ask how follow-up is scheduled, how results are communicated, and whom to contact with prescription questions between appointments. A lower or higher first-visit price alone does not answer whether the ongoing process suits your needs. The returning-visit price is one part of that discussion, not a full projection of future spending.
Use the Visit Map to prioritize the clinical and administrative questions that would affect your decision. You can ask about hormone and non-hormonal options without arriving with a self-selected prescription. A clinician’s assessment, exact product information, and your preferences belong together in the visit.
Continue with A menopause appointment starts with three good questions.
Where Midi fits in this comparison
Midi is worth examining when an explicitly described visit structure and a plan-checking process are important to you. CoreAge Rx remains our featured provider, with separate pages for estrogen, progesterone, thyroid replacement, and a named non-hormonal medication. Alloy uses another consultation and product-price structure.
Compare the exact service, current booking arrangements, and a written total from each provider. This publication does not award clinical-superiority scores or turn public testimonials into evidence of typical outcomes. Its provider notes help you identify the questions that remain before making a choice.
Continue with CoreAge Rx midlife care review: four pages to read before a visit.
Sources for this story
Public pages are a dated snapshot. A provider page supports its published description, not a clinical outcome or a completed service audit.